Dianthus Therapeutics DNTH
NASDAQ DNTH
$78.74 -0.01 (-0.01%)
As of: Oct 21, 2026 · 11:41 AM EDT

Dianthus Therapeutics (DNTH) Change in Receivables (2025)

Updated

Dianthus Therapeutics (DNTH) recorded Change in Receivables of $4.96 million in Q3 2025.

Analysis

Dianthus Therapeutics (DNTH) Change in Receivables (2025) Analysis & Trends

On a TTM basis, Dianthus Therapeutics' Change in Receivables came in at $5 million as of Sep 30, 2025.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn -
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 1.35 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 1.37 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 333.00 Mn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn -
10 Dianthus Therapeutics 2.97 Bn 2.92 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 4.96 Mn
Jun 30, 2025 -961,000.00
Mar 31, 2025 1.00 Mn
API Access

Dianthus Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=DNTH&period=max&api_key=YOUR_API_KEY